The Patent Finder
US

Methods of Treating Obesity Using Antioxidant Inflammation Modulators

US 10,105,372 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Oct 23, 2026 on the fee record · Low confidence

Second maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.

Filed Apr 12, 2011 as application 13/085,338 · Granted Oct 23, 2018
Base term, 20 years from filing, plus 120 days of patent term adjustment (USPTO delay)
Today
Lapsed Oct 23, 2026
2011 2031
Clock starts
Apr 12, 2011
No longer in force
Oct 23, 2026
Granted
Oct 23, 2018
Term would have run to
Aug 10, 2031
base term patent term adjustment after the term ends fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
120
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Aug 10, 2031: its 20-year base term plus 120 days of term adjustment for prosecution delay. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 12, 2011, when this application, 13/085,338, was filedApr 12, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+120 days, USPTO patent term adjustment recordAug 10, 2031High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee eventsNo fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case"lapsed Oct 23, 2026Low confidence
Computed term endThe steps above, in orderOct 23, 2026Low confidence

This family

US 10,105,372this patent
Oct 2026
Oct 2026
US 11,911,395In force
Aug 2031
Aug 2031
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 10, 2011
Reel 26427, frame 698
Meyer, Colin J.; Huff, WarrenReata PharmaceuticalsAssignment of Assignor's Interest
Aug 23, 2012
Reel 28840, frame 735
Meyer, Colin J.; Huff, J. WarrenReata Pharmaceuticals, Inc.Corrective Assignment to Correct the Name of the Assignee Previously Recorded on Reel 026427 Frame 0698. Assignor(S) Hereby Confirms the the Entire Right, Title, and Interest for the United States and All Foreign Countries in and to Any and All Improvements.
Jun 14, 2018
Reel 46357, frame 605
Reata Pharmaceuticals, Inc.Oxford Finance LLC, as Collateral AgentSecurity Interest
Jun 24, 2020
Reel 53034, frame 18
Oxford Finance LLC, as Collateral AgentReata Pharmaceuticals, Inc.Release of Security Interest
Jan 4, 2022
Reel 58639, frame 138
Reata Pharmaceuticals, Inc.Reata Pharmaceuticals Holdings, LLCAssignment of Assignor's Interest
May 18, 2023
Reel 63697, frame 461
Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc.Biopharma Credit PLCPatent Security Agreement
Jul 12, 2023
Reel 64264, frame 557
Reata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc.Biopharma Credit PLCAmended and Restated Patent Security Agreement
Apr 9, 2025
Reel 70793, frame 228
Biopharma Credit PLCReata Pharmaceuticals Holdings, LLC; Reata Pharmaceuticals Global, Inc.; Reata Pharmaceuticals, Inc.Release of Security Interest
Apr 9, 2025
reel/frame not recorded
Biopharma Credit PLCReata Pharmaceuticals Holdings, LLCRelease of Security Interest
Apr 9, 2025
reel/frame not recorded
Biopharma Credit PLCReata Pharmaceuticals Global, Inc.Release of Security Interest
Apr 9, 2025
reel/frame not recorded
Biopharma Credit PLCReata Pharmaceuticals, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited